# Updated Egyptian national guidelines for management of hemophilia A in children & adolescents

**Authors:** Galila Mokhtar, Amal El-Beshlawy, Mohsen El Alfy, Magdy El Ekiaby, Magda Rakha, Ahmed Mansour, Azza A.G. Tantawy, Hoda Hassab, Usama El Safy, Khaled A. Eid, Naglaa Shaheen, Naglaa Omar, Sonia Adolf, Seham Ragab, Mohamed ElKholy, Nayera H.K. Elsherif

PMC · DOI: 10.1007/s00277-025-06557-x · Annals of Hematology · 2025-10-09

## TL;DR

The paper presents updated Egyptian guidelines for managing hemophilia A in children and adolescents to better address local healthcare needs.

## Contribution

The novel contribution is the updated national guidelines for Hemophilia A care in Egypt, incorporating new aspects like obesity management and patient advocacy.

## Key findings

- The guidelines now include management of obesity and oral health in hemophilia patients.
- New protocols for central nervous system bleeding and acquired hemophilia are introduced.
- Transitional care and patient advocacy are emphasized in the updated guidelines.

## Abstract

To improve patient advocacy in hemophilia, the World Federation of Hemophilia (WFH) recommends establishing a National Hemophilia Committee (NHC), developing standards and guidelines, broadening the community through including people with von Willebrand disease, other rare bleeding disorders and carriers of hemophilia. In 2018, the Egyptian Society of Hemophilia (ESH) took the initiative, developed, and published guidelines for Hemophilia A care [1] (Table 1). Aim & Methods given the cmanagement, the panel `s goal was to update the ESH guidelines for Hemophilia A care using the modified Delphi method to address unmet needs and local requirements in Egyptian healthcare settings and include management of obesity in hemophilia patients, oral health promotion and prophylaxis before dental procedures, routine monitoring of bleeding events and musculoskeletal scoring, treatment of central nervous system bleeding in children and neonates with hemophilia, the management of acquired hemophilia and hemophilia carrier, the use and monitoring of Non-factor replacement in prophylaxis, finally the implementation of transitional care and patient advocacy.

## Linked entities

- **Diseases:** hemophilia A (MONDO:0010602), von Willebrand disease (MONDO:0019565), acquired hemophilia (MONDO:0019139)

## Full-text entities

- **Diseases:** central nervous system bleeding (MESH:D002493), obesity (MESH:D009765), Hemophilia (MESH:D006467), bleeding (MESH:D006470), von Willebrand disease (MESH:D014842)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12619826/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12619826/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC12619826/full.md

---
Source: https://tomesphere.com/paper/PMC12619826